Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Oct 12 2023
Business
Oct 12 2023
3 min read

Press Release Oct 12 2023

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "Ichnos Sciences Enters Licensing Agreement For OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics".

View Attachment